Amicus Therapeutics, Inc. (FOLD) to Announce Third Quarter 2012 Financial Results on November 5, 2012  
11/2/2012 7:39:13 AM

CRANBURY, N.J., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced a conference call and live audio webcast on Monday, November 5, 2012 at 5:00 p.m. ET to discuss financial results for the third quarter ended September 30, 2012.